Gene expression signatures, stromal tumor infiltrating lymphocytes (sTILs), and change in tumor cellularity to predict pathological complete response (pCR) after 12 week de-escalated neoadjuvant endocrine therapy (ET) vs paclitaxel + dual HER2 blockade in the WSG-TP-II trial
| Title: | Gene expression signatures, stromal tumor infiltrating lymphocytes (sTILs), and change in tumor cellularity to predict pathological complete response (pCR) after 12 week de-escalated neoadjuvant endocrine therapy (ET) vs paclitaxel + dual HER2 blockade in the WSG-TP-II trial |
|---|---|
| Authors: | Graeser, Monika Karla1 (AUTHOR), Gluz, Oleg1 (AUTHOR), Nitz, Ulrike1 (AUTHOR), Biehl, Claudia2 (AUTHOR), Berg, Angela1 (AUTHOR), Christgen, Matthias3 (AUTHOR), Kuemmel, Sherko1 (AUTHOR), Holtschmidt, Johannes4 (AUTHOR), Schumacher, Johannes5 (AUTHOR), Hartkopf, Andreas D.6 (AUTHOR), Potenberg, Jochem7 (AUTHOR), Luedtke-Heckenkamp, Kerstin8 (AUTHOR), Just, Marianne9 (AUTHOR), Schem, Christian10 (AUTHOR), zu Eulenburg, Christine1 (AUTHOR), Schinkoethe, Timo11 (AUTHOR), Wuerstlein, Rachel1 (AUTHOR), Kates, Ronald E.1 (AUTHOR), Kreipe, Hans Heinrich3 (AUTHOR), Harbeck, Nadia1 (AUTHOR) |
| Source: | Journal of Clinical Oncology. 2023 Supplement 16, Vol. 41, p519-519. 1p. |
| Database: | Supplemental Index |
| ISSN: | 0732183X |
|---|---|
| DOI: | 10.1200/JCO.2023.41.16_suppl.519 |
| Published in: | Journal of Clinical Oncology |
| Language: | English |